Immune Checkpoint Inhibitor Therapy as a Novel and Effective Therapy for Aggressive Cutaneous Squamous Cell Carcinoma

被引：0
|
作者：
Beasley, G. [2 ]
Kurtz, J. [1 ]
Howard, J. H. [2 ]
Terando, A. [2 ]
Agnese, D. [2 ]
David, L. [2 ]
Olencki, T. [2 ]
机构：
[1] Doctors Hosp, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2017年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
88
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [41] Immune Checkpoint Inhibitor Therapy Toxicities
    Jim, Heather S. L.
    Knoop, Hans
    Dicker, Adam P.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (01): : 87 - 87
  • [42] Exosomal MicroRNA Levels Associated with Immune Checkpoint Inhibitor Therapy in Clear Cell Renal Cell Carcinoma
    Ivanova, Elizaveta
    Asadullina, Dilara
    Gilyazova, Gulshat
    Rakhimov, Radmir
    Izmailov, Adel
    Pavlov, Valentin
    Khusnutdinova, Elza
    Gilyazova, Irina
    BIOMEDICINES, 2023, 11 (03)
  • [43] Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
    Lee, Chung-Han
    Motzer, Robert
    BRITISH JOURNAL OF CANCER, 2018, 119 (08) : 911 - 912
  • [44] Immune Checkpoint Inhibitor Therapy Before Nephrectomy for Locally Advanced and Metastatic Renal Cell Carcinoma
    Ghoreifi, Alireza
    Vaishampayan, Ulka
    Yin, Ming
    Psutka, Sarah P.
    Djaladat, Hooman
    JAMA ONCOLOGY, 2024, 10 (02) : 240 - 248
  • [45] Combination VEGFR/immune checkpoint inhibitor therapy: a promising new treatment for renal cell carcinoma
    Chung-Han Lee
    Robert Motzer
    British Journal of Cancer, 2018, 119 : 911 - 912
  • [46] Combination of peptide receptor radionuclide therapy and immune checkpoint inhibitor in metastatic Merkel cell carcinoma
    Moghadam, Soroush Zarehparvar
    Manafi-Farid, Reyhaneh
    Nghiem, Paul
    Gunnell, Lindsay
    Askari, Emran
    IRANIAN JOURNAL OF NUCLEAR MEDICINE, 2024, 32 (01): : 99 - 101
  • [47] Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review
    Li, Jin
    Luo, Zhenqin
    Jiang, Siqing
    Li, Junjun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [48] The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
    Knepper, Todd C.
    Montesion, Meagan
    Russell, Jeffery S.
    Sokol, Ethan S.
    Frampton, Garrett M.
    Miller, Vincent A.
    Albacker, Lee A.
    McLeod, Howard L.
    Eroglu, Zeynep
    Khushalani, Nikhil, I
    Sondak, Vernon K.
    Messina, Jane L.
    Schell, Michael J.
    DeCaprio, James A.
    Tsai, Kenneth Y.
    Brohl, Andrew S.
    CLINICAL CANCER RESEARCH, 2019, 25 (19) : 5961 - 5971
  • [49] Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
    Pestana, Roberto Carmagnani
    Becnel, Melody
    Rubin, Maria Laura
    Torman, Danice K.
    Crespo, James
    Phan, Jack
    Hanna, Ehab
    Bell, Diana
    Glisson, Bonnie S.
    Johnson, Jason M.
    Lee, J. Jack
    Ferrarotto, Renata
    ORAL ONCOLOGY, 2020, 101
  • [50] Determinants of neoadjuvant immune checkpoint inhibitor plus tyrosine kinase inhibitor therapy response in renal cell carcinoma
    Gu, L.
    Liang, Q.
    Zhang, X.
    Wang, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1507 - S1507
12345